Cynthia Seidel-Dugan
2022
In 2022, Cynthia Seidel-Dugan earned a total compensation of $1.2M as Chief Scientific Officer at Werewolf Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $172,724 |
|---|---|
| Option Awards | $610,524 |
| Salary | $416,000 |
| Other | $11,630 |
| Total | $1,210,878 |
Seidel-Dugan received $610.5K in option awards, accounting for 50% of the total pay in 2022.
Seidel-Dugan also received $172.7K in bonus, $416K in salary and $11.6K in other compensation.
Rankings
In 2022, Cynthia Seidel-Dugan's compensation ranked 2,658th out of 5,760 executives tracked by ExecPay. In other words, Seidel-Dugan earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,658 out of 5,760 | 54th |
Division Manufacturing | 1,477 out of 3,136 | 53rd |
Major group Chemicals And Allied Products | 678 out of 1,422 | 52nd |
Industry group Drugs | 631 out of 1,323 | 52nd |
Industry Pharmaceutical Preparations | 455 out of 969 | 53rd |
Source: SEC filing on April 27, 2023.
Seidel-Dugan's colleagues
We found three more compensation records of executives who worked with Cynthia Seidel-Dugan at Werewolf Therapeutics in 2022.